NASDAQ: INCYIncyte Corp Stock Ownership - Who owns Incyte?
Insider buying vs selling
Have Incyte Corp insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Paul J. Clancy | Director | 2026-05-19 | 15,000 | $94.93 | $1.42MSell |
| Paul J. Clancy | Director | 2026-05-19 | 15,000 | $84.53 | $1.27MBuy |
| Baker Bros Advisors LP | Director | 2026-05-08 | 15,000 | $84.53 | $1.27MBuy |
| Baker Bros Advisors LP | Director | 2026-05-08 | 15,000 | $84.53 | $1.27MBuy |
| Pablo J. Cagnoni | President Global Head of RD | 2026-04-17 | 6,077 | $64.25 | $390.45kBuy |
| Pablo J. Cagnoni | President Global Head of RD | 2026-04-17 | 18,667 | $96.50 | $1.80MSell |
| Pablo J. Cagnoni | President Global Head of RD | 2026-04-17 | 12,590 | $71.93 | $905.60kBuy |
| Paul J. Clancy | Director | 2026-03-31 | 265 | $94.12 | $24.94kBuy |
| Edmund Harrigan | Director | 2026-03-31 | 269 | $94.12 | $25.32kBuy |
| Matteo Trotta | EVP GM Dermatology US | 2026-03-25 | 537 | $92.23 | $49.53kSell |
INCY insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when INCY insiders and whales buy or sell their stock.
INCY Shareholders
What type of owners hold Incyte Corp stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Baker Bros Advisors LP | 15.39% | 30,744,412 | $2.99B | Institution |
| Julian Baker | 9.94% | 19,851,744 | $1.93B | Insider |
| Blackrock Inc | 9.50% | 18,978,198 | $1.85B | Institution |
| Baker Brothers Life Sciences LP | 6.23% | 12,445,783 | $1.21B | Insider |
| Baker Brothers Life Sciences Capital GP LLC | 6.22% | 12,430,783 | $1.21B | Insider |
| Dodge Cox | 6.13% | 12,252,356 | $1.19B | Institution |
| Vanguard Capital Management LLC | 5.47% | 10,930,066 | $1.06B | Institution |
| State Street Corp | 4.83% | 9,641,384 | $939.17M | Institution |
| Vanguard Portfolio Management LLC | 3.88% | 7,759,183 | $755.82M | Institution |
| Aqr Capital Management LLC | 2.91% | 5,807,930 | $565.75M | Institution |
INCY vs Biotech Stocks
Incyte Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.